GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Highnoon Laboratories Ltd (KAR:HINOON) » Definitions » Gross Profit

Highnoon Laboratories (KAR:HINOON) Gross Profit : ₨12,518 Mil (TTM As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Highnoon Laboratories Gross Profit?

Highnoon Laboratories's gross profit for the three months ended in Dec. 2024 was ₨3,335 Mil. Highnoon Laboratories's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was ₨12,518 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Highnoon Laboratories's gross profit for the three months ended in Dec. 2024 was ₨3,335 Mil. Highnoon Laboratories's Revenue for the three months ended in Dec. 2024 was ₨6,306 Mil. Therefore, Highnoon Laboratories's Gross Margin % for the quarter that ended in Dec. 2024 was 52.89%.

Highnoon Laboratories had a gross margin of 52.89% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 12 years, the highest Gross Margin % of Highnoon Laboratories was 51.79%. The lowest was 46.78%. And the median was 47.65%.


Highnoon Laboratories Gross Profit Historical Data

The historical data trend for Highnoon Laboratories's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Highnoon Laboratories Gross Profit Chart

Highnoon Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,242.76 6,523.72 8,190.44 9,398.16 12,517.63

Highnoon Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,458.94 3,023.24 2,965.43 3,194.03 3,334.93

Competitive Comparison of Highnoon Laboratories's Gross Profit

For the Drug Manufacturers - General subindustry, Highnoon Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Highnoon Laboratories's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Highnoon Laboratories's Gross Profit distribution charts can be found below:

* The bar in red indicates where Highnoon Laboratories's Gross Profit falls into.


;
;

Highnoon Laboratories Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Highnoon Laboratories's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=24629.506 - 12111.88
=12,518

Highnoon Laboratories's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=6305.58 - 2970.651
=3,335

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨12,518 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Highnoon Laboratories's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=3,335 / 6305.58
=52.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Highnoon Laboratories  (KAR:HINOON) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Highnoon Laboratories had a gross margin of 52.89% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Highnoon Laboratories Gross Profit Related Terms

Thank you for viewing the detailed overview of Highnoon Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Highnoon Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.

Highnoon Laboratories Headlines

No Headlines